Cardinal Health is recalling 38 syringes of Nucala (mepolizumab) Injection, 100 mg/mL, because the medication was stored and shipped outside of its required temperature range. This drug is a prescription medication used for subcutaneous injection. Because the medication was not kept at the correct temperature, its effectiveness and safety cannot be guaranteed. Consumers who have received these specific syringes should contact their healthcare provider or pharmacist immediately.
Storing medication outside of its labeled temperature requirements, known as temperature abuse, can cause the drug to break down or lose its potency. This means the medication may not work as intended to treat the patient's condition, or it could potentially cause an adverse reaction.
Healthcare provider consultation and pharmacy refund.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.